Skip to content

Study to compare the Efficacy of Siravedha versus Distal Sodium Channel Block in the Management of Sciatca (Grudrasi)

A Randomized Controlled Trial to Assess the Efficacy of Siravedha and Distal Sodium Channel Block in the Management of Grudhrasi w.s.r Sciatica - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085001
Enrollment
40
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Siravedha: The procedure will be performed in three stages as Purva Karma (Pre-procedures), Pradhana Karma (Main- procedures), and Paschata Karma (Post- procedures) mentioned as per SOP

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: Patients of either gender between 25-60 years. Patient having typical clinical feature pertaining to the Sciatica like Constant aching pain felt in the lumbar region and may radiate to the buttock, thigh, calf and foot. Diagnosed case of Sciatica through Positive Passive SLRT and Buckling test . Patients having normal CT, BT and Hb above 10gm percent will undergo Siravedha Patient willing to undergo trial.

Exclusion criteria

Exclusion criteria: Patients with infectious diseases of spine. Patient with infection at the site of DSCB infiltration and Siravedha. Patients with past history of or ongoing malignancy or chemotherapy or radiotherapy Patients with uncontrolled Diabetes mellitus, Cardiovascular diseases, HIV,Hypertension Pregnant or Lactating Females. Patients with known hypersensitivity

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms of Sciatica. Change in VAS, MRSS Score , SLR &Buckling test. Timepoint: BASELINE And 57 Days

Secondary

MeasureTime frame
Change in the quality of life of the patient.( as per SF-12 Questionnaire).Timepoint: BASELINE And 57 Days

Countries

India

Contacts

Public ContactDr Manorama Singh

National Institute of Ayurveda

doc.manorma@gmail.com7414810997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026